Information Provided By:
Fly News Breaks for March 18, 2016
Mar 18, 2016 | 14:11 EDT
Mizuho analyst Eric Criscuolo thinks Thermo Fisher (TMO) has room to counter Origin Technologies' offer for Affymetrix (AFFX) and it still be a good acquisition. If Thermo raises its bid, even to something "modestly above" $16.10 per share, the takeover valuation would still be "reasonable," Criscuolo tells investors in a research note after Origin announced a bid of $16.10 per share for Affymetrix. Other companies that could receive buyout attention should Thermo walk away include Fluidigm (FLDM), Luminex (LMNX) and NanoString (NSTG), the analyst contends.
News For AFFX;TMO;FLDM;LMNX;NSTG From the Last 2 Days
There are no results for your query AFFX;TMO;FLDM;LMNX;NSTG